George Medicines Announces GMRx2 NDA Filing to FDA

5 months ago

by David Miller

945 Views

Written by David Miller

London, UK 6 August 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic disease, today announces its submission to the US Food and Drug Administration (FDA) of…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!